Your browser doesn't support javascript.
loading
Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment.
Liu, Liang; Huo, Shuping; Liu, Jianghui; Li, Qiaomin; Wang, Jing.
Afiliação
  • Liu L; Hebei Provincial Cancer Institute, Shijiazhuang, Hebei 050011, China.
  • Huo S; Department of Anesthesiology, the third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China.
  • Liu J; Hebei Provincial Cancer Institute, Shijiazhuang, Hebei 050011, China.
  • Li Q; Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei 050021, China.
  • Wang J; Hebei Provincial Cancer Institute, Shijiazhuang, Hebei 050011, China.
Discov Med ; 31(164): 141-146, 2021.
Article em En | MEDLINE | ID: mdl-35188888
ABSTRACT
A large number of studies on the metabolism of immune cells in anti-tumor response have been carried out in recent years. It is proved that metabolic reprogramming can determine the differentiation and functions of immune cells. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immunosuppressive cells in the tumor microenvironment (TME). They can significantly inhibit the anti-tumor response of T cells and play an important role in promoting tumor growth, metastasis, and invasion. This review summarizes the energy metabolic pathways of MDSCs in the TME, such as fatty acid oxidation (FAO), glycolysis, and amino acids (AAs) metabolism, and highlights the importance of metabolic reprogramming of MDSCs for its immunosuppressive functions.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Supressoras Mieloides / Neoplasias Limite: Humans Idioma: En Revista: Discov Med Ano de publicação: 2021 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Supressoras Mieloides / Neoplasias Limite: Humans Idioma: En Revista: Discov Med Ano de publicação: 2021 Tipo de documento: Article